Sex-Related Bleeding Risk in Acute Coronary Syndrome Patients Receiving Dual Antiplatelet Therapy with Aspirin and a P2Y12 Inhibitor
Medical Principles and Practice · 2023 · 32 (3) · 200-208
DOI: 10.1159/000529863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Principles and Practice, online erschienen am 22.03.2023. Verfasst von Monique E Ten Haaf und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
The aim of this work was to study sex differences in major bleeding risk in relation to dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Methods and Results: The Rijnmond Collective Cardiology Research registry was designed to evaluate the application and outcomes of DAPT after ACS/PCI in the Rijnmond region in the Netherlands. Overall, 1,172 women (median age 67.5 years) and 3,087 men (median age 62.2 years) with ACS/PCI were enrolled between August 2011 and June 2013. Based on a tailored regional DAPT guideline aiming at bleeding risk minimization, 52.6% women and 66.9% men received prasugrel as first-choice P2Y12 inhibitor, in addition to aspirin. Women more frequently had contraindications for the use of prasugrel (and therefore received clopidogrel) than men (47.9 vs. 26.9%, p < 0.001). Femoral access was more common in women than in men (47.6 vs. 38.1%, p < 0.001). Women had higher incidence of major bleeding at 1 year than men (2.6 vs. 1.6%, p = 0.018). After adjustment for established bleeding risk factors, female sex was associated with over two-fold higher risk of major bleeding (adjusted hazard ratio 2.33; 95% confidence interval 1.26–4.32). This difference was apparent at discharge and appeared to be caused by access site bleedings (0.9 vs. 0.1%, p < 0.001). No sex differences were found in non-access site-related major bleeding up to 1 year.
Conclusion
Women with ACS/PCI receiving DAPT had higher major bleeding risk caused by an excess in access site bleeds, mainly in relation to the femoral approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands.
- The Netherlands Heart Institute, Utrecht, The Netherlands.
- Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands.
- Department of Cardiology, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands.
- Department of Cardiology, Maasstad Hospital, Rotterdam, The Netherlands.
- Department of Cardiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Zitieren
APA
Ten Haaf, M. E., van Geuns, R. J., van der Linden, M. M. J. M., Smits, P. C., de Vries, A. G., Doevendans, P. A., Appelman, Y., & Boersma, E. (2023). Sex-Related Bleeding Risk in Acute Coronary Syndrome Patients Receiving Dual Antiplatelet Therapy with Aspirin and a P2Y12 Inhibitor. Medical Principles and Practice, 32(3), 200-208. https://doi.org/10.1159/000529863
Vancouver
Ten Haaf ME, van Geuns RJ, van der Linden MMJM, Smits PC, de Vries AG, Doevendans PA, et al. Sex-Related Bleeding Risk in Acute Coronary Syndrome Patients Receiving Dual Antiplatelet Therapy with Aspirin and a P2Y12 Inhibitor. Medical Principles and Practice. 2023;32(3):200-208. doi:10.1159/000529863
BibTeX
@article{TenHaaf2023,
author = {Ten Haaf, Monique E and van Geuns, Robert-Jan and van der Linden, Marc M J M and Smits, Pieter C and de Vries, Arie G and Doevendans, Pieter A and Appelman, Yolande and Boersma, Eric},
title = {Sex-Related Bleeding Risk in Acute Coronary Syndrome Patients Receiving Dual Antiplatelet Therapy with Aspirin and a P2Y12 Inhibitor},
journal = {Medical Principles and Practice},
year = {2023},
volume = {32},
number = {3},
pages = {200--208},
doi = {10.1159/000529863}
}
EUVIMED